Journal of Novel Physiotherapies
Open Access

Abstract

The role of a Respiratory Physiotherapist is vital for Patients with Respiratory diseases like COPD, ILD, Asthma, Lung Cancer, Respiratory Failure by interventions like Maintaining Oximetry, O2 therapy, Teaching Inhaler techniques, Bronchial hygiene techniques, Chest PT, 6MWT, Mobilization etc. But still NIV remains underutilized by Physiotherapists. NIV has been evolved from Big Machines (in 1950) to Smart Devices (in 2000). It is a provision of Assisted Ventilation without Endotracheal Intubation. Studies have shown Underutilization of NIV & Low rates of perceived efficacy as Major findings. Reasons for Low utilization like Physician�s Lack of knowledge, Equipments not appropriate, Respiratory staff inadequately trained & poor previous experience are major among others. There are many studies which prove the benefits of NIV. Strongest evidence is in COPD and Acute Cardiogenic Pulmonary edema where NIV prevents Intubation. NIV Use Improves Chances of Survival in Acute Respiratory Failure. It tends to reduce mortality in ICU, hospital & reduces need for therapeutic interventions. I will be discussing in this session Basics of NIV � Patient selection/ Indications/ Contraindications/ Settings & Parameters/ Initiation/ Optimization/ Goals of NIV, the different devices & interfaces available, monitoring of patients on NIV, criteria for NIV success or failure- identification/ causes/ rectification, common problems & solutions of using NIV and clinical evidence on NIV.

Biography

Email: dr_palak4324@yahoo.com